1. 12LBA Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French national AcSe Program. Issue 3 (September 2015) Authors: Vassal, G.; Moro-sibilot, D.; Le Deley, M.C.; Hoog-labouret, N.; Nowak, F.; Jimenez, M.; Tournigand, C.; Houot, R.; Malka, D.; Aparicio, T.; Escudier, B.; Ray-coquard, I.; Godbert, Y.; Taillandier, L.; Bieche, I.; Lantuejoul, S.; Ferretti, G.; Menu, Y.; Blay, J.Y.; Buzyn, A. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S715 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗